The Telescopic Intra-Ocular Lens for Visually Impaired People (IOL-VIP) Revolution System (iolAMD) shows promise for patients with retinal diseases. Its use can provide at least twice the best-corrected visual level (BCVA) that the patients had at baseline, as well as improve their quality of life.
“Age-related macular degeneration (AMD) and other retinal diseases, such as Stargardt’s disease and cone dystrophies, affect many people worldwide by reducing their levels of visual acuity (VA),” Fabio Patelli, MD, said. “Numerous visual aids–ranging from magnifiers, extra-strong glasses, telescopic glasses, and other electronic devices–are available to help these patients. Surgical approaches, such as macular translocation and choroidal grafts, have had less than satisfactory results.”
However, the intraocular telescope might offer higher levels of vision than those obtained in this low-vision patient population. “The intraocular telescope is a technology that retinal surgeons might not have considered,” he added.
Dr. Patelli is a vitreoretinal surgeon, director of vitreoretinal service, ASST Santi Paolo e Carlo Hospital, University of Milan, Italy.